News

09/07/2020

Sant Pau leads the way in the creation of a new nanodrug that blocks the tumour cells of acute myeloid leukaemia without damaging healthy ones

Acute myeloid leukemia is a very heterogeneous disease, the usual treatment is very aggressive and with severe side effects. In the investigation of a new, more effective drug, researchers led by the ...

01/07/2020

Sant Pau receives a donation of a collection of sculptures and paintings that will enable two research projects to be started in the field of pregnancy, childbirth and the postpartum period for women affected by the Covid-19

Patricia Cancelo, sculptor, painter and journalist, has donated a collection of sculptures and paintings, valued at 10,000 euros, to the Sant Pau, in order to start two research projects in the field ...

29/06/2020

Lina Badimon joins the Advisory Board of the Berlin Institute of Health

The Berlin State Senate, at the proposal of the Mayor of this city and the Senator for Science and Research, Michael Müller, recently appointed Lina Badimon, director of the "ICCC Cardiovascular Prog...

28/06/2020

For the first time, the Hospital of Sant Pau, the Catalan Foundation for Down and the University of Cambridge describe the natural history of Alzheimer’s disease in people with Down syndrome

One of the world’s leading medical journals, The Lancet, published the article ‘Clinical and biomarker changes of Alzheimer’s disease in adults with Down syndrome: a cross-sectional study’, le...

23/06/2020

New pathway discovered to improve the cardioprotective potential of HDL and which is diminished in familial hypercholesterolemia

Researchers in the research group on the Metabolic Basis of Cardiovascular Risk at the Sant Pau Research Institute, attached to CIBERDEM, led by Juan Carlos Escolà-Gil and Francisco Blanco-Vaca, have...